RDH11

Across TCGA pan-cancer cohorts, RDH11 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated RDH11 data layer compared with 26 for mass-spec protein and 3 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher RDH11 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated RDH11 expression acts as an unfavorable survival marker, although some lineages such as CCRCC show a favorable association.

CCRCC, LUAD, and UCEC are the cancer types where RDH11 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	OS	Tertile	All	0.946	0.753	.003	13	view →
LUAD	DFS	Quartile	II,III,IV	0.217	0.762	.016	8	view →
UCEC	DFS	Quartile	All	0.798	1.000	.027	4	view →
PDAC	OS	Tertile	IV	0.472	0.934	.024	3	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RDH11–CCRCC (OS)

Open the CCRCC breakdown →